Clinic for Radiology and Nuclear Medicine, University Hospital Magdeburg, Leipziger Str. 44, 39120, Magdeburg, Germany.
Department of General-, Visceral-, Vascular- and Transplantation Surgery, University Hospital Magdeburg, Magdeburg, Germany.
Langenbecks Arch Surg. 2022 Jun;407(4):1369-1379. doi: 10.1007/s00423-022-02541-5. Epub 2022 May 18.
To assess the influence of low skeletal muscle mass (LSMM) on post-operative complications in patients with hepatic malignancies grade (Clavien Dindo ≥ 3) undergoing resection.
MEDLINE, Cochrane, and SCOPUS databases were screened for associations between sarcopenia and major post-operative complications (≥ grade 3 according to Clavien-Dindo classification) after resection of different malignant liver tumors. RevMan 5.3 software was used to perform the meta-analysis. The methodological quality of the included studies was assessed according to the QUIPS instrument.
The analysis included 17 studies comprising 3157 patients. Subgroup analyses were performed for cholangiocarcinoma (CCC), colorectal cancer (CRC) liver metastases, and hepatocellular carcinoma (HCC). LSMM as identified on CT was present in 1260 patients (39.9%). Analysis of the overall sample showed that LSMM was associated with higher post-operative complications grade Clavien Dindo ≥ 3 (OR 1.56, 95% CI 1.25-1.95, p < 0.001). In the subgroup analysis, LSMM was associated with post-operative complications in CRC metastases (OR 1.60, 95% CI 1.11-2.32, p = 0.01). In HCC and CCC sub-analyses, LSMM was not associated with post-operative complications in simple regression analysis.
LSMM is associated with major post-operative complications in patients undergoing surgery for hepatic metastases and it does not influence major post-operative complications in patients with HCC and CCC.
评估低骨骼肌量(LSMM)对接受肝恶性肿瘤切除术(Clavien Dindo≥3 级)患者术后并发症的影响。
对 MEDLINE、Cochrane 和 SCOPUS 数据库进行筛选,以评估在切除不同恶性肝肿瘤后,肌少症与主要术后并发症(根据 Clavien-Dindo 分类≥3 级)之间的关联。使用 RevMan 5.3 软件进行荟萃分析。根据 QUIPS 工具评估纳入研究的方法学质量。
分析纳入了 17 项研究,共 3157 名患者。对胆管癌(CCC)、结直肠癌(CRC)肝转移和肝细胞癌(HCC)进行了亚组分析。CT 上识别的 LSMM 存在于 1260 名患者(39.9%)中。对总体样本的分析表明,LSMM 与较高的术后并发症 Clavien Dindo 分级≥3 相关(OR 1.56,95%CI 1.25-1.95,p<0.001)。在亚组分析中,LSMM 与 CRC 转移的术后并发症相关(OR 1.60,95%CI 1.11-2.32,p=0.01)。在 HCC 和 CCC 的亚组分析中,LSMM 与术后并发症无显著相关性。
LSMM 与接受肝转移手术患者的主要术后并发症相关,而与 HCC 和 CCC 患者的主要术后并发症无关。